Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination

Toxicology Letters

Volumn 164, Issue 3, 2006, Pages 278-288

  Bernauer, Ulrike ^a   Heinrich Hirsch, Barbara ^a   Tönnies, Mario ^b   Peter Matthias, Wolski ^a   Gundert Remy, Ursula ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b Zentralklinik Emil von Behring   (Germany)

Author keywords

CYP450; Enzyme expression; Human lung; Interindividual variability; Local metabolism

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A; CYTOCHROME P450 2B6; CYTOCHROME P450 2C; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; ETHOXYRESORUFIN DEETHYLASE; OXYGENASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; METABOLIC DETOXICATION, DRUG; MICROSOMES; XENOBIOTICS;

EID: 33646769588     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.01.007     Document Type: Article

References (50)

1. Anttila S., Vainio H., Hietanen E., Camus A.M., Malaveille C., Brun G., Husgafvel-Pursiainen K., Heikkilä L., Karjaleinen A., and Bartsch H. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients. Environ. Health Perspect. 98 (1992) 179-182
2. Anttila S., Hukkanen J., Hakkola J., Stjernvall T., Beaune P., Edwards R.J., Boobis A.R., Pelkonen O., and Raunio H. Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J. Respir. Cell Mol. Biol. 16 (1997) 242-249
3. Anttila S., Tuominen P., Hirvonen A., Nurminen M., Karjalainen A., Hankinson O., and Elovaara E. CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11 (2001) 501-509
4. Bernauer U., Vieth B., Ellrich R., Heinrich-Hirsch B., Jänig G.-R., and Gundert-Remy U. CYP2E1 expression in the bone marrow and its intra- and interspecies variability. Approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals. Arch. Toxicol. 73 (2000) 618-624
5. Bernauer U., Ellrich R., Heinrich-Hirsch B., Teubner W., Vieth B., and Gundert-Remy U. Expression of cytochrome P450 enzymes in human colon. IARC Sci. Publ. 156 (2002) 487-489
6. Bernauer U., Heinrich-Hirsch B., and Gundert-Remy U. Immunochemical determination of xenobiotic-metabolizing cytochrome P450 (P450) enzymes in human CD34+ bone marrow stem cells. Naunyn Schmiedebergs Arch. Pharmacol. 367 (2003) R129
7. Botto F., Seree E., Khyari S.E., de Sousa G., Massacrier A., Placidi M., Cau P., Pellet W., Rahmani R., and Barra Y. Tissue-specific expression and methylation of the human CYP2E1 gene. Biochem. Pharmacol. 48 (1994) 1095-1103
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
9. Chen Y., Liu Y.-Q., Su T., Ren X., Shi L., Liu D., Gu J., Zhang Q.Y., and Ding X. Immunoblot analysis and immunohistochemical characterization of CYP2A expression in human olfactory mucosa. Biochem. Pharmacol. 66 (2003) 1245-1251
10. Csanady G.A., Guengerich F.P., and Bond J.A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13 (1992) 1143-1153
11. Ding X., and Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 149-173
12. Forkert P.G., Premdas P.D., and Bowers R.J. Epoxide formation from diallyl sulfone is associated with CYP2E1 inactivation in murine and human lungs. Am. J. Respir. Cell Mol. Biol. 23 (2000) 687-695
13. Gerde P., Muggenburg B.A., Scott G.G., Lewis J.L., Pyon K.H., and Dahl A.R. Local metabolism in lung airways increases the uncertainty of pyrene as a biomarker of polycyclic aromatic hydrocarbon exposure. Carcinogenesis 19 (1998) 493-500
14. Gervot L., Rochat B., Gautier J.C., Bohnenstengel F., Kroemer H., de Berardinis V., Martin H., Beaune P., and de Waziers I. Human CYP2B6: expression, inducibility and catalytic activities. Pharmacogenetics 9 (1999) 295-306
15. Guengerich F.P., Kim D.H., and Iwasaki M. Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4 (1991) 168-179
16. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91 (1999) 1194-1210
17. Hukkanen J., Pelkonen O., Hakkola J., and Raunio H. Expression and regulation of xenobiotic metabolizing Cytochrome P450 (CYP) enzymes in human lung. Crit. Rev. Toxicol. 32 (2002) 391-411
18. Hukkanen J., Pelkonen O., and Raunio H. Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD. Eur. Respir. J. 18 Suppl. 32 (2001) 122s-126s
19. Imaoka S., Asai S., Sugimoto T., Hiroi T., and Funae Y. Comparison of human CYP4B1 with that of other species. Proceedings of the 11th International Conference on Cytochrome P450 (1999) 148 (Abstract)
20. Kennedy S.W., and Jones S.P. Simultaneous measurement of Cytochrome P4501A catalytic activity and total protein concentration with a fluorescence plate reader. Anal. Biochem. 222 (1994) 217-223
21. Kennedy S.W., Jones S.P., and Bastien L.J. Efficient analysis of cytochrome P4501A catalytic activity, porphyrins, and total proteins in chicken embryo hepatocyte cultures with a fluorescence plate reader. Anal. Biochem. 226 (1995) 362-370
22. Kim R.B., Yamazaki H., Chiba K., O'Shea D., Mimura M., Guengerich F.P., Ishizaki T., Shimada T., and Wilkinson G.R. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J. Pharmacol. Exp. Ther. 279 (1996) 4-11
23. Kivistö K.T., Griese E.-U., Fritz P., Linder A., Hakkola J., Raunio H., Beaune P., and Kroemer H.K. Expression of cytochrome P4503A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumors. Naunyn Schmiedebergs Arch. Pharmacol. 353 (1996) 207
24. Kivistö K.T., Griese E.-U., Stüven T., Fritz P., Friedel G., Kroemer H.K., and Zanger U.M. Analysis of CYP2D6 expression in human lung: implications for the association between CYP2D6 activity and susceptibility to lung cancer. Pharmacogenetics 7 (1997) 295-302
25. Lo Guidice J.-M., Marez D., Sabbagh N., Legrand-Andreoletti M., Spire C., Alcaide E., Lfitte J.-J., and Broly F. Evidence for CYP2D6 expression in human lung. Biochem. Biophys. Res. Commun. 241 (1997) 79-85
26. Mace K., Bowman E.D., Vautravers P., Shields P.G., Harris C.C., and Pfeifer A.M.A. Characterisation of Xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 34 (1998) 914-920
27. Mc Cully S., Boobis A., Philpot R., Borlak J., and Hawksworth G. Characterisation of human lung drug-oxidising enzymes. Proceedings of the 12th International Symposium on Microsomes and Drug Oxidations (1998) (Abstract)
28. Newton D.J., Wang R.W., and Lu A.Y.H. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 23 (1995) 154-158
29. Nhamburo P.T., Kimura S., McBride O.W., Kozak C.A., Gelboin H.V., and Gonzalez F.J. The human CYP2F gene subfamily: identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping. Biochemistry 29 (1990) 5491-5499
30. Omiecinski C.J., Redlich C.A., and Costa P. Induction and developmental expression of Cytochrome P450!A1 messenger RNA in rat and human tissues. Cancer Res. 50 (1990) 4315-4321
31. Peter R., Böcker R., Beaune P.H., Ixasaki M., Guengerich F.P., and Yang C.S. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3 (1990) 566-573
32. Raucy J.L., Schultz E.D., Wester M.R., Arora S., Johnston D.E., Omdahl J.L., and Carpenter S.P. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab. Dispos. 25 (1997) 1429-1435
33. Raunio H., Hakkola J., Hukkanen J., Pelkonen O., Edwards R., Boobis A., and Anttila S. Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues. Arch. Toxicol. Suppl. 20 (1998) 465-469
34. Rendic S., and DiCarlo F.J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab. Dispos. 29 (1997) 413-580
35. Runge D.M., Stock T.W., Lehmann T., Taege C., Bernauer U., Stolz D.B., Hofmann S., and Foth H. Expression of cytochrome P450 2E1 in normal human bronchial epithelial cells and activation by ethanol in culture. Arch. Toxicol. 75 (2001) 335-345
36. Rylander T., Neve E.P., Ingelmann-Sundberg M., and Oscarson M. Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem. Biophys. Res. Commun. 281 (2001) 529-535
37. Shimada T., Yamakazi H., Mimura M., Wakamiya N., Ueng Y.F., Guengerich F.P., and Inui Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab. Dispos. 25 (1996) 515-522
38. Siekevitz P. Preparation of microsomes and submicrosomal fractions: mammalian. Methods Enzymol. 5 (1962) 61-68
39. Simmonds A.C., Ghanayem B.I., Sharma A., Reilly C.A., Millen B., Yost G.S., and Forkert P.G. Bioactivation of 1,1-dichloroethylene by CYP2E1 and CYP2F2 in murine lung. J. Pharmacol. Exp. Ther. 310 (2004) 855-864
40. Smith G.B.J., Harper P.A., Wong J.M.Y., Lam M.S.M., Reid K.R., Petsikas D., and Massey T.E. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 839-853
41. Song B.J., Veech R.L., and Saenger P. CytochromeP450IIE1 is elevated in lymphocytes from poorly controlled isulin-dependent diabetics. J. Clin. Endocrinol. Metab. 71 (1990) 1036-1040
42. Spivack S.D., Hurteau G.J., Reilly A.A., Aldous K.M., Ding X., and Kaminsky L. CYP1B1 expression in human lung. Drug Metab. Dispos. 29 (2001) 916-922
43. Tang Y.M., Chen G.F., Thompson P.A., Lin D.X., Lang N.P., and Kadlubar F.F. Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1. Drug Metab. Dispos. 27 (1999) 274-280
44. Tassaneeyakul W., Birkett D.J., Veronese M.E., McManus M.E., Tukey R.H., Quattrochi L.C., Gelboin H.V., and Miners J.O. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J. Pharmacol. Exp. Ther. 265 (1993) 401-407
45. Thum T., and Borlak J. Gene expression in distinct regions of the heart. Lancet 335 (2000) 979-983
46. Venkarakrishnan K., von Moltke L.L., Court M.H., Harmatz J.S., Crespi C.L., and Greenblatt D.J. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratio of accessory proteins as sources of discrepancies between the approaches. Drug Metab. Dispos. 28 (2000) 1493-1504
47. Wei C., Cacavale R.J., Kehoe J.J., Thomas P.E., and Iba M.M. CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett. 164 (2001) 25-32
48. Wheeler C.W., Park S.S., and Guenthner T.M. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes. Mol. Pharmacol. 36 (1990) 634-643
49. Wheeler C.W., Wrighton S.A., and Guenthner T.M. Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 44 (1992) 183-186
50. Zeldin C.D., Foley J., Ma J., Boyle J.E., Pascual J.M.S., Moomaw C.R., Tomer K.B., Steenbergen C., and Wu S. CYP2J Subfamily P450s in the lung: expression, localization, and potential functional significance. Mol. Pharmacol. 50 (1996) 1111-1117